Last Build Date: Mon, 20 Feb 2017 00:30:16 ESTCopyright: copyright © 2017 Dow Jones & Company, Inc.
Wed, 15 Feb 2017 09:47:10 ESTCigna called off the roughly $48 billion merger with Anthem and filed a lawsuit against its suitor, the second such health-insurer deal to fall apart.
Tue, 14 Feb 2017 18:37:01 ESTMerck & Co. said Tuesday it stopped a clinical trial of an experimental Alzheimer’s drug because it wasn’t helping patients.
Tue, 14 Feb 2017 22:08:05 ESTThe nonprofit National Academies of Sciences and the National Academy of Medicine commissioned a study of the ethical, scientific and regulatory questions raised by editing genes in sperm, eggs and early-stage embryos.
Mon, 13 Feb 2017 18:05:35 ESTEvan Morris, a high-flying corporate lobbyist, is suspected by federal prosecutors of embezzling millions of dollars from his employers, Roche and then Genentech. The probe is shaping up to be one of the biggest Washington influence scandals in years.
Mon, 13 Feb 2017 23:05:01 ESTTeva Pharmaceuticals swung to a loss on an acquisition write-down, as its interim CEO contends with a deal-driven debt load, though shares rose as the company beat revenue and profit expectations.
Tue, 14 Feb 2017 10:01:14 ESTMarathon Pharmaceuticals will delay the U.S. launch of its muscular dystrophy drug amid mounting criticism of its $89,000-a-year price, including from two members of Congress who launched an investigation Monday.
Mon, 13 Feb 2017 17:46:54 ESTAllergan PLC said it would buy Zeltiq Aesthetics Inc., the maker of a fat-reducing treatment, for $2.26 billion.
Tue, 14 Feb 2017 00:37:45 ESTThe American College of Physicians says back pain of all kinds should be treated with natural and alternative therapies, such as exercise, acupuncture and mindfulness.
Sun, 12 Feb 2017 20:24:18 ESTHospital officials say President Donald Trump’s executive order leaves them with a difficult choice: forgo strong residency candidates from countries named in the order or risk vacancies if foreign doctors are barred from the U.S.
Sat, 11 Feb 2017 00:09:51 ESTMarathon Pharmaceuticals will charge $89,000 annually in the U.S. for a decades-old steroidal drug that was approved for U.S. sale for the first time on Thursday, a price that is as much as 70 times higher than the drug’s price overseas.
Fri, 10 Feb 2017 17:14:42 ESTReckitt Benckiser said it agreed to buy baby-food maker Mead Johnson for $16.6 billion, a cash deal that will almost double the size of the British company’s consumer-health business and help it push deeper into emerging markets.
Fri, 10 Feb 2017 16:47:52 ESTThe Georgia Republican was approved in a party-line vote Friday morning, placing him atop a sprawling agency tasked with dismantling the Affordable Care Act.